Fellowship in Addiction Psychiatry
The UCLA/VA Greater Los Angeles Addiction Psychiatry Fellowship Program is a fully ACGME accredited one-year fellowship program for residents entering their PGY-5 year after completion of a General Psychiatry Residency Program. The predominant mission of the program is to provide psychiatric physicians with advanced training in the knowledge, skills, and clinical judgment necessary for the practice of Addiction Psychiatry to allow them to undertake leadership roles in the field. Clinical training occurs in outpatient, intensive outpatient, and residential treatment programs, pain clinic settings, acute detoxification, and methadone clinic settings. Fellows gain expertise using all FDA approved pharmacotherapies for substance use disorders as well as evidence-based group therapy training. Formal didactics include participation in a weekly seminar series involving collaboration with an interdisciplinary team. Rotations occur at Greater Los Angeles VA and UCLA-based sites.
The primary goals of fellowship training include developing clinical excellence in the diagnosis and treatment of individuals with substance use disorders with or without primary psychiatric diagnoses, broadening scientific knowledge in the field of Addiction Psychiatry, and expanding expertise in teaching Addiction Psychiatry. Closely working with a range of interdisciplinary treatment teams is a major aspect of the fellowship. The faculty consists of a diverse group of psychiatrists and psychologists who have many years of clinical and research experience in the field of substance use disorders.
If you have further questions, please feel free to call or email the Program Director, Larissa Mooney M.D. at email@example.com or the Associate Program Director, Muhammad Iqbal, M.D. at Muhammad.Iqbal2@va.gov. We look forward to hearing from you.
Larissa Mooney, M.D.
Larissa Mooney, M.D. is an Associate Professor and Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biobehavioral Sciences at UCLA. She directs the UCLA Addiction Psychiatry Clinic and the UCLA-VA Addiction Psychiatry Fellowship Program, where she teaches psychiatrists in training in the clinical management of substance use and mental health disorders. Dr. Mooney served as the Section Chief for Substance Use Disorders at the Greater Los Angeles VA from 2015-2021. She is the President-Elect of the American Academy of Addiction Psychiatry (AAAP). Dr. Mooney has conducted research at UCLA Integrated Substance Abuse Programs (ISAP) on pharmacological and behavioral treatment interventions for addictive disorders. She is one of two Principal Investigators for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network.
Muhammad N Iqbal, M.D.
Muhammad N Iqbal, M.D. is a graduate of Dow Medical College in Pakistan. He completed his general psychiatry residency from New Jersey and combined addiction psychiatry/NIDA T-32 research fellowship from Columbia University in the city of New York. He is the Associate Program Director of UCLA/VA Greater Los Angeles Addiction Psychiatry Fellowship Program. He is also the Medical Director, Substance Use Disorder Clinics at Sepulveda VA (SACC VA), Greater Los Angeles. His responsibilities include management of substance use disorders clinic at Sepulveda VA, teaching psychiatry residents and fellows, and faculty presentations. His research interest lies in evaluating role of biomarkers in substance use disorders. He conducted research evaluating the feasibility of rapid induction onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users. He has also authored and coauthored original articles, abstracts, book chapters and poster presentations. His outside passion includes travelling, exercising and watching movies.
Timothy Fong, M.D.
Dr. Timothy Fong is a Clinical Professor of Psychiatry at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA. Dr. Fong completed his undergraduate and medical school at Northwestern University in Chicago. He then came to UCLA and finished his residency in adult general psychiatry in 2002 and was the first accredited addiction psychiatry fellow at the UCLA Neuropsychiatric Institute (2002-2004). He is the co-director of the UCLA Gambling Studies Program (UGSP) and serves on the Steering Committee for the UCLA Cannabis Research Initiative. He was the Program Director of the UCLA Addiction Psychiatry Fellowship from 2009-2021 and is currently the Director of the UCLA Addiction Psychiatry Consult Service.
Karen Miotto, M.D.
Dr. Karen Miotto is a Clinical Professor in the Department of Psychiatry and Behavioral Sciences at UCLA and the director of the UCLA Physician and Faculty Wellness Program, Behavioral Wellness Program and chair of the Medical Staff Health Committee. Dr. Miotto is the immediate past Chair of California Public Protection & Physician Health (CPPPH) and is the president-elect of the California Society of Addiction Medicine (CSAM). She is dedicated to promoting physician wellness and educating others on how to reduce physician distress, burnout, substance misuse, and mental illness in the medical profession. Additionally, Dr. Miotto is a frequently invited speaker at local and international addiction medicine meetings. She is the recipient of a career development award from the National Institute on Drug Abuse and her area of is research addiction pharmacology.
Joy Hao, M.D.
Dr. Joy Hao is an addiction physician with board certification in both internal medicine and addiction medicine (American Board of Addiction Medicine). She is the Medical Director of the West Los Angeles VA Substance Use Disorders Clinic, as well as Assistant Professor of Clinical Health Sciences at UCLA Department of Family Medicine, Center for Behavioral and Addiction Medicine (CBAM). She teaches fellows and residents from a variety of disciplines including psychiatry, Family Medicine, and Pain Management/Anesthesiology in the management of substance use disorders, with emphasis on opioid addiction as it intersects with chronic pain. She has conducted research at UCLA CBAM in two large multi-site NIH studies evaluating the efficacy of extended-release gabapentin Enacarbil for the treatment of alcohol use disorder, and effectiveness of combining bupropion and injectable extended-release naltrexone in treatment of methamphetamine use disorder.
Binyamin Amrami, M.D.
Dr. Binyamin Amrami is a graduate of Sackler School of Medicine at Tel Aviv University, Israel. He started his general psychiatry residency at St. Vincent’s Hospital – Manhattan and completed residency at Cedars-Sinai Medical Center in Los Angeles. He is board-certified in general psychiatry, addiction medicine and is an Assistant Clinical Professor of Psychiatry at UCLA. He is the Medical Director of the West Los Angeles VA Domiciliary.
Katherine Bailey, Ph.D.
Katherine Bailey, PhD, is a licensed clinical psychologist at the W. Los Angeles VA and the Deputy Chief of the SUD Section for the VA Greater Los Angeles Healthcare System. She provides clinical services and supervision in the outpatient SUD and Pain Clinics with a focus on evidence-based therapies. She earned a PhD in clinical psychology from the University of Illinois at Chicago, completed a clinical internship at the WLA VA, and a clinical fellowship in primary care at the San Francisco VA. She is a consultant for the CBT-Chronic Pain evidence based psychotherapy rollout, and is also certified in biofeedback, acceptance and commitment therapy (ACT), and mindfulness. Research interests include chronic pain, SUD and smoking.